Who owns AVIR?
Institutional ownership of Atea Pharmaceuticals Inc. from Form 13F, Q2 2026
125 institutional managers reported holding Atea Pharmaceuticals Inc. (AVIR) in Form 13F filings for Q2 2026, with 59,434,917 shares worth $276M. The largest reported holder was FMR LLC. Managers that filed both quarters cut a net 660,600 shares (-1.1%). 18 opened new positions and 20 sold out.
- Funds holding
- 125
- Value held
- $276M
- New / sold out
- 18 / 20
- Net shares, same filers
- -1.1%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of AVIR
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $55.8M | 20.2% | 12,004,064 | Added |
| BlackRock, Inc. | $40.5M | 14.7% | 8,720,077 | Added |
| BML Capital Management, LLC | $32.3M | 11.7% | 6,952,330 | Trimmed |
| Tang Capital Management LLC | $22.4M | 8.1% | 4,814,700 | Unchanged |
| Vanguard Capital Management LLC | $13.8M | 5.0% | 2,964,862 | Trimmed |
| Bain Capital Life Sciences Investors, LLC | $9.7M | 3.5% | 2,075,639 | Trimmed |
| Acadian Asset Management LLC | $9.5M | 3.4% | 2,035,192 | Added |
| Geode Capital Management, LLC | $9.1M | 3.3% | 1,958,435 | Added |
| State Street Corp | $7.7M | 2.8% | 1,652,399 | Trimmed |
| Two Sigma Investments, LP | $7.0M | 2.5% | 1,506,697 | Trimmed |
| Dimensional Fund Advisors LP | $6.0M | 2.2% | 1,299,515 | Added |
| Renaissance Technologies LLC | $5.3M | 1.9% | 1,131,200 | Trimmed |
| Rosalind Advisors, Inc. | $5.0M | 1.8% | 1,070,550 | Trimmed |
| JPMorgan Chase & Co | $4.4M | 1.6% | 945,918 | Added |
| Northern Trust Corp | $3.5M | 1.3% | 755,239 | Added |
| Morgan Stanley | $3.3M | 1.2% | 719,514 | Trimmed |
| Vanguard Portfolio Management LLC | $2.9M | 1.1% | 630,185 | Added |
| Charles Schwab Investment Management Inc | $2.8M | 1.0% | 610,607 | Added |
| Goldman Sachs Group Inc | $2.5M | 0.9% | 530,856 | Trimmed |
| Vanguard Fiduciary Trust Co | $2.2M | 0.8% | 469,801 | Trimmed |
| CM Management, LLC | $1.7M | 0.6% | 355,000 | Unchanged |
| Barclays PLC | $1.6M | 0.6% | 348,653 | Added |
| D. E. Shaw & Co., Inc. | $1.6M | 0.6% | 345,186 | Trimmed |
| Banque Pictet & Cie SA | $1.6M | 0.6% | 345,077 | Unchanged |
| Millennium Management LLC | $1.4M | 0.5% | 304,611 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 59,434,917 AVIR shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Acadian Asset Management LLC Added+$2.1M
- BlackRock, Inc. Added+$1.3M
- Quantinno Capital Management LP Added+$1.1M
- Geode Capital Management, LLC Added+$980K
- AQR Capital Management LLC Added+$937K
- Barclays PLC Added+$873K
- Northern Trust Corp Added+$791K
- Wellington Management Group LLP Added+$696K
- Invesco Ltd. Added+$622K
- Citadel Advisors LLC Added+$506K
Biggest sellers in Q2 2026
- Jane Street Group, LLC Sold out-$2.3M
- Two Sigma Investments, LP Trimmed-$1.7M
- Irenic Capital Management LP Sold out-$1.6M
- Peapod Lane Capital LLC Sold out-$1.4M
- Bain Capital Life Sciences Investors, LLC Trimmed-$1.3M
- Vanguard Capital Management LLC Trimmed-$1.3M
- Point72 Asset Management, L.P. Sold out-$643K
- Sei Investments Co Trimmed-$639K
- Informed Momentum Co LLC Sold out-$607K
- BML Capital Management, LLC Trimmed-$494K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $12.8M and sold $16.9M; 45 added and 38 trimmed.
Schedule 13D and 13G filings on AVIR
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-10-06TANG CAPITAL MANAGEMENT LLC SCHEDULE 13G filed by Atea Pharmaceuticals Inc.Schedule 13G
- 2026-02-09BML Investment Partners, L.P. SCHEDULE 13G filed by Atea Pharmaceuticals Inc.Schedule 13G
- 2025-03-04Radoff Bradley Louis SCHEDULE 13D filed by Atea Pharmaceuticals Inc.Schedule 13D
Questions about AVIR ownership
- Who owns AVIR stock?
- 125 institutional investment managers reported AVIR positions in their Form 13F filings for Q2 2026, holding 59,434,917 shares worth $276M in total. FMR LLC reported the largest position.
- Are funds buying or selling AVIR?
- In Q2 2026, 18 managers opened new AVIR positions, 45 added, 38 trimmed and 20 sold out. Managers that filed in both quarters sold a net 660,600 shares.
- How current is this AVIR institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AVIR by CUSIP. Options are left out. AVIR news and filings · AVIR insider trades · Top funds